Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Pacira BioSciences	ALX Oncology	Nektar Therapeutics	CytoDyn	Global Blood Therapeutics
Symbol	NASDAQ:PCRX	NASDAQ:ALXO	NASDAQ:NKTR	OTCMKTS:CYDY	NASDAQ:GBT
Price Information
Current Price	$72.56	$87.68	$23.62	$4.52	$44.48
52 Week Range	Buy	Buy	Hold	Hold	Buy
MarketRank™
Overall Score	1.9	1.9	1.1	0.7	1.6
Analysis Score	2.3	1.5	1.1	1.0	4.4
Community Score	2.9	3.8	3.0	2.6	3.0
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	3.3	1.7	0.0	0.0
Earnings & Valuation Score	4.4	0.6	0.0	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	Hold	Buy
Consensus Price Target	$76.09	$89.60	$25.11	$4.00	$93.82
% Upside from Price Target	4.87% upside	2.19% upside	6.31% upside	-11.50% downside	110.93% upside
Trade Information
Market Cap	$3.15 billion	$3.25 billion	$4.24 billion	$2.75 billion	$2.75 billion
Beta	1.27	N/A	1.76	-0.64	1.39
Average Volume	563,608	193,000	1,528,685	4,277,168	1,104,273
Sales & Book Value
Annual Revenue	$421.03 million	N/A	$114.62 million	N/A	$2.11 million
Price / Sales	7.49	N/A	36.97	N/A	1,302.69
Cashflow	$1.70 per share	N/A	N/A	N/A	N/A
Price / Cash	42.56	N/A	N/A	N/A	N/A
Book Value	$8.51 per share	N/A	$7.99 per share	($0.01) per share	$9.61 per share
Price / Book	8.53	N/A	2.96	N/A	4.63
Profitability
Net Income	$-11,020,000.00	N/A	$-440,670,000.00	$-124,400,000.00	$-266,770,000.00
EPS	$0.86	N/A	($2.52)	($0.21)	($4.71)
Trailing P/E Ratio	25.55	0.00	N/A	N/A	N/A
Forward P/E Ratio	25.19	N/A	N/A	∞	N/A
P/E Growth	0.82	N/A	N/A	N/A	N/A
Net Margins	29.95%	N/A	-269.05%	N/A	-332.94%
Return on Equity (ROE)	10.71%	N/A	-30.74%	N/A	-56.43%
Return on Assets (ROA)	4.88%	N/A	-22.63%	-153.30%	-39.32%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.78%	N/A	N/A	5.01%	0.16%
Current Ratio	7.63%	N/A	8.25%	1.13%	7.63%
Quick Ratio	6.84%	N/A	8.15%	0.28%	7.20%
Ownership Information
Institutional Ownership Percentage	N/A	73.45%	95.32%	0.10%	N/A
Insider Ownership Percentage	5.80%	N/A	2.99%	7.80%	4.30%
Miscellaneous
Employees	606	17	723	19	352
Shares Outstanding	43.44 million	37.11 million	179.40 million	608.41 million	61.80 million
Next Earnings Date	5/6/2021 (Estimated)	3/4/2021 (Estimated)	5/6/2021 (Estimated)	4/8/2021 (Estimated)	5/5/2021 (Estimated)
Optionable	Optionable	Not Optionable	Optionable	Not Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources